🔎 Trials Near Me

Home › NCT05025865

HA35 Acute Alcohol Study

RecruitingEarly phase 1Healthy volunteers welcome

Mechanisms by Which HA35 Regulates Muscle Protein Homeostasis in Healthy Controls

Who can join

Ages 21 to 65 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Alcohol consumption of less than 7 drinks per week for women and less than 14 drinks per week for men
* Ability to understand and willingness to provide written consent

Exclusion Criteria:

* Any known chronic illness including but not limited to cancer (except non-melanoma skin cancer)
* Poorly controlled diabetes (Hemoglobin A1c \>9.5 g/dl)
* Untreated hyper/hypothyroidism
* Uncontrolled hypertension or hypercholesterolemia
* End-stage renal disease
* Liver disease of any etiology
* Coronary artery disease or stroke
* Active intravenous drug use
* History of gastric bypass
* Medications known to alter muscle protein synthesis (systemic corticosteroids, tamoxifen, high dose estrogen, testosterone, or anabolic steroids)
* Pregnancy
* Past alcohol use disorder
* Abnormal clotting factors

About the study

Eligible subjects will be asked to take a placebo/treatment capsule for a total of 3 days and then participate in a study visit on the fourth day. This study visit will include a medical exam, clinical labs, questionnaires, body composition measurements, and urine and stool collections. Additionally, participants will consume a sugar cocktail to measure their gut permeability, participate in an acute ethanol challenge, and undergo two muscle biopsies. The study will take approximately 3-4 hours and a designated driver will need to drive the participant home. On the fifth day, you will be asked to return to drop of the 24-hour urine collection.

What is being tested

Sponsor: The Cleveland Clinic · Participants: 24 · Started: Feb 1, 2022

Contact the study team

Official record on ClinicalTrials.gov — NCT05025865

Locations in the U.S.

OhioCleveland Clinic, Cleveland

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.